Heard on the Street: After months of threats, President Trump eased up on drugmakers late last year. That’s all it took for investors to notice that the beaten-down sector was actually growing.
Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve. Source link




